These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 19159285)

  • 1. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.
    Carmona S; Jorgensen MR; Kolli S; Crowther C; Salazar FH; Marion PL; Fujino M; Natori Y; Thanou M; Arbuthnot P; Miller AD
    Mol Pharm; 2009; 6(3):706-17. PubMed ID: 19159285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.
    Morrissey DV; Blanchard K; Shaw L; Jensen K; Lockridge JA; Dickinson B; McSwiggen JA; Vargeese C; Bowman K; Shaffer CS; Polisky BA; Zinnen S
    Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of hepatitis B virus replication and expression by RNA interference in vivo].
    Ying RS; Fan XG; Zhu C; Li N; Zhang BX
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):15-8. PubMed ID: 16420758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line.
    Konishi M; Wu CH; Wu GY
    Hepatology; 2003 Oct; 38(4):842-50. PubMed ID: 14512871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [RNA interference inhibits replication and expression of hepatitis B virus in mice].
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):630-4. PubMed ID: 15949363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA.
    Kim HR; Kim IK; Bae KH; Lee SH; Lee Y; Park TG
    Mol Pharm; 2008; 5(4):622-31. PubMed ID: 18461969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
    J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
    Shin D; Kim SI; Kim M; Park M
    Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable inhibition of hepatitis B virus expression and replication by expressed siRNA.
    Ren GL; Bai XF; Zhang Y; Chen HM; Huang CX; Wang PZ; Li GY; Zhang Y; Lian JQ
    Biochem Biophys Res Commun; 2005 Oct; 335(4):1051-9. PubMed ID: 16111658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J; Feng SS; Wang S; Chen ZY
    Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the encapsulation of short interfering RNA in PEGylated cationic liposomes.
    Buyens K; Demeester J; De Smedt SS; Sanders NN
    Langmuir; 2009 May; 25(9):4886-91. PubMed ID: 19341292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.